Richard Barrett Laub

US Patent:

6524566, Feb 25, 2003

Filed:

Oct 9, 2001

Appl. No.:

09/974658

Inventors:

Richard J. Laub - Newport Beach CA

Assignee:

Laub Biochemicals Corp. - Newport Beach CA

International Classification:

A61K 3174

US Classification:

424 7802, 424 7837, 514456, 528207, 528180

Abstract:

Phenolic polymers are prepared by oxidizing and polymerizing starting organic compounds comprising at least one hydroxyl group and at least one carbonyl group or at least two hydroxyl groups on an aromatic structure. One or more inorganic compounds or salts is added and the solution is allowed to stand at about 20Â C. to 80Â C. for a period of about at least 2 hours. Salt molecules as well as starting compounds and other low molecular-weight materials below about 500 to about 10,000 daltons are removed from the product solution. Purified phenolic polymers are prepared in concentrated aqueous solution or in dried powder form in a final step if necessary. The resultant phenolic polymers exhibit physicochemical properties strongly resembling those of typical commercially-available natural-product soil extracts. The materials are active herpes anti-viral agents, and are effective in anti-viral compositions for treating or preventing human herpes viral diseases.

US Patent:

6524567, Feb 25, 2003

Filed:

Oct 11, 2001

Appl. No.:

09/976513

Inventors:

Richard J. Laub - Newport Beach CA

Assignee:

Laub Biochemicals Corp. - Newport Beach CA

International Classification:

A61K 3174

US Classification:

424 7802, 42419511, 514456

Abstract:

Phenolic polymers are prepared by oxidizing and polymerizing starting organic compounds comprising at least one hydroxyl group and at least one carbonyl group or at least two hydroxyl groups on an aromatic structure. One or more inorganic compounds or salts is added and the solution is allowed to stand at about 20Â C. to 80Â C. for a period of about at least 2 hours. Salt molecules as well as starting compounds and other low molecular-weight materials below about 500 to about 10,000 daltons are removed from the product solution. Purified phenolic polymers are prepared in concentrated aqueous solution or in dried powder form in a final step if necessary. The resultant phenolic polymers exhibit physicochemical properties strongly resembling those of typical commercially-available natural-product soil extracts. The materials are active hemorrhagic fever anti-viral agents, and are effective in anti-viral compositions for treating or preventing hemorrhagic fever viral diseases.

US Patent:

6534049, Mar 18, 2003

Filed:

Oct 11, 2001

Appl. No.:

09/976557

Inventors:

Richard J. Laub - Newport Beach CA

Assignee:

Laub BioChemicals Corp. - Newport Beach CA

International Classification:

A61K 3174

US Classification:

424 7802, 514456

Abstract:

Phenolic polymers are prepared by oxidizing and polymerizing starting organic compounds comprising at least one hydroxyl group and at least one carbonyl group or at least two hydroxyl groups on an aromatic structure. One or more inorganic compounds or salts is added and the solution is allowed to stand at about 20Â C. to 80Â C. for a period of about at least 2 hours. Salt molecules as well as starting compounds and other low molecular-weight materials below about 500 to about 10,000 daltons are removed from the product solution. Purified phenolic polymers are prepared in concentrated aqueous solution or in dried powder form in a final step if necessary. The resultant phenolic polymers exhibit physicochemical properties strongly resembling those of typical commercially-available natural-product soil extracts. The materials are active human immunodeficiency anti-viral agents, and are effective in anti-viral compositions for treating or preventing human immunodeficiency viral diseases.

US Patent:

6569416, May 27, 2003

Filed:

Jul 1, 1999

Appl. No.:

09/345865

Inventors:

Richard J. Laub - Newport Beach CA

Assignee:

Lamb Biochemicals Corp. - Newport Beach CA

International Classification:

A61K 3174

US Classification:

424 7802, 42419511, 514456

Abstract:

Compositions for treating viral and bacterial diseases are described. The compositions contain a synthetic soil phenolic polymeric material which contains sulfur, boron, alkaline earth, or transition metals but does not contain nitrogen. The synthetic materials may be synthetic humic acids or fulvic acids. The polymeric materials in the compositions are prepared by oxidizing one or more organic phenols in the presence of inorganic salts. Polymeric materials prepared from organic phenols having at least one carboxylic acid group are especially effective. The compositions can be injected, applied topically, ingested, inhaled, or applied as a suppository.

US Patent:

6576229, Jun 10, 2003

Filed:

May 8, 2002

Appl. No.:

10/141477

Inventors:

Richard J. Laub - Newport Beach CA

Assignee:

Laub Biochemicals Corp. - Newport Beach CA

International Classification:

A61K 3174

US Classification:

424 7802, 424 4837, 514456

Abstract:

Phenolic polymers are prepared by oxidizing and polymerizing starting organic compounds comprising at least one hydroxyl group and at least one carbonyl group or at least two hydroxyl groups on an aromatic structure. One or more inorganic compounds or salts is added and the solution is allowed to stand at about 20Â C. to 80Â C. for a period of about at least 2 hours. Salt molecules as well as starting compounds and other low molecular-weight materials below about 500 to about 10,000 daltons are removed from the product solution. Purified phenolic polymers are prepared in concentrated aqueous solution or in dried powder form in a final step, if necessary. The resultant phenolic polymers exhibit physicochemical properties strongly resembling those of typical commercially-available natural-product soil extracts. The materials are active influenza anti-viral agents, and are effective in anti-viral compositions for treating or preventing influenza viral diseases.

US Patent:

59454466, Aug 31, 1999

Filed:

Feb 10, 1997

Appl. No.:

8/798329

Inventors:

Richard J. Laub - Newport Beach CA

Assignee:

Laubc Biochemicals, Corporation - Newport Beach CA

International Classification:

A61K 3135
A01N 3578

US Classification:

514456

Abstract:

Phenolic polymers are prepared by dissolving one or more organic phenols along with sodium periodate in aqueous base at pH 8-11, and allowing the mixtures to stand between 35 and 80. degree. C. for a period of 30 minutes to 100 hours. One or more inorganic compounds or salts is added and the solution is allowed to stand at room temperature between 2 and 48 hours. Salt molecules as well as starting compounds and other low molecular-weight materials below about 500 to about 10,000 daltons are removed from the product solutions. Purified phenolic polymers are prepared in concentrated aqueous solution or in dried powder form in a final step if necessary. The resultant phenolic polymers exhibit physicochemical properties strongly resembling those of typical commercially-available natural soil extracts. The materials are active anti-viral and anti-microbial agents, and are effective in anti-viral amounts in blood product compositions, in methods for reducing or eliminating virus in blood products and in anti-viral and anti-microbial compositions for treating or preventing human or animal viral or microbial diseases.